跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GD-12
首页
药物
GD-12
GD-12
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method of enhancing immune responses to herpes
US 2004067484 A1
申请人: MISHKIN ERIC M
优先权: 2002
US
2 件公开
Magnetic resonance imaging contrast agent having bone tissue targeting detection based on metal fullerene and the preparation thereof
CN 101062421 A
申请人: CHINESE ACAD INST CHEMISTRY
优先权: 2006
CN
2 件公开
Anti-tumor vaccine
US 2003082136 A1
申请人: MINSHALL BILL
优先权: 2001
US
Method for preparing paramagnetic polyphosphazene nanotube magnetic resonance imaging contrast agent
CN 101891897 B
申请人: UNIV JIANGSU
优先权: 2010
CN
Method for preparing gadolinium oxide-based magnetic resonance contrast agent by biomineralization method
CN 107982551 A
申请人: UNIV NATIONAL DONG HWA
优先权: 2017
CN
Inactivated vaccine strain CH-GD-12-2014 against duck adenovirus type 3
CN 108330108 A
申请人: UNIV SOUTH CHINA AGRICULT
优先权: 2017
CN
Preparation method of magnetic fluorescent nano-composite
CN 112745843 A
申请人: BEIJING INST PETROCHEM TECH
优先权: 2020
CN
Carboxyl functionalized ionic liquid-Gd complexes as magnetic resonance contrast agents
CN 115068635 A
申请人: UNIV BEIJING TECHNOLOGY & BUSINESS
优先权: 2021
CN
KRAS MODULATORS AND USES THEREOF
WO 2023154766 A1
申请人: QUANTA THERAPEUTICS INC
优先权: 2022
WO
一种具有高弛豫率长循环时间的钆基磁共振对比剂合成方法及应用
CN 115317628 B
申请人: 华中科技大学同济医学院附属协和医院
优先权: 2022
CN
第 1 / 2 页
上一页
下一页
药物
反馈